In today’s recent session, 0.78 million shares of the Bionomics Ltd. ADR (NASDAQ:BNOX) have been traded, and its beta is -0.17. Most recently the company’s share price was $0.24, and it changed around -$0.01 or -3.40% from the last close, which brings the market valuation of the company to $3.16M. BNOX at last check was trading at a discount to its 52-week high of $3.03, offering almost -1162.5% off that amount. The share price’s 52-week low was $0.23, which indicates that the recent value has risen by an impressive 4.17% since then. We note from Bionomics Ltd. ADR’s average daily trading volume that its 10-day average is 2.36 million shares, with the 3-month average coming to 960.18K.
Bionomics Ltd. ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended BNOX as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Bionomics Ltd. ADR is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bionomics Ltd. ADR (NASDAQ:BNOX) trade information
Instantly BNOX has been showing red trend so far today with a performance of -3.40% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3800 on recent trading dayincreased the stock’s daily price by 36.84%. The company’s shares are currently down -83.89% year-to-date, but still down -19.32% over the last five days. On the other hand, Bionomics Ltd. ADR (NASDAQ:BNOX) is -62.74% down in the 30-day period. We can see from the shorts that 13778.0 shares have been sold at a short interest cover period of 0.05 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 96.0% from its current value. Analyst projections state that BNOX is forecast to be at a low of $6 and a high of $6.
Bionomics Ltd. ADR (BNOX) estimates and forecasts
Bionomics Ltd. ADR share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -76.40 percent over the past six months and at a 18.08% annual growth rate that is well above the industry average of 17.50%. Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 14.53%.
BNOX Dividends
Bionomics Ltd. ADR’s next quarterly earnings report is expected to be released on 2022-Aug-29.
Bionomics Ltd. ADR (NASDAQ:BNOX)’s Major holders
LYNX1 CAPITAL MANAGEMENT LP, with 6.3212% or 0.6 million shares worth $0.46 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
